Literature DB >> 27171676

Management of Conjunctival Melanoma: Critical Assessment of Sentinel Lymph Node Biopsy.

Hassan A Aziz1, Brian R Gastman1, Arun D Singh1.   

Abstract

Conjunctival melanoma (CoM) is a rare and aggressive form of melanoma. There is a lack of consensus on a unified management plan for this disease. Recently, a few centers have adopted the regional sentinel lymph node biopsy into the staging process of CoM. This study presents a critical assessment of the role of sentinel lymph node biopsy in CoM and presents a simplified management algorithm based on high-risk clinical and pathological features.

Entities:  

Keywords:  Aggressive form; Conjunctival melanoma; Sentinel lymph node biopsy

Year:  2015        PMID: 27171676      PMCID: PMC4847666          DOI: 10.1159/000381719

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  37 in total

1.  Sentinel node biopsy for orbital and ocular adnexal tumors.

Authors:  M W Wilson; J C Fleming; R M Fleming; B G Haik
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2001-09       Impact factor: 1.746

2.  Sentinel lymph node biopsy in patients with conjunctival and eyelid cancers: experience in 17 patients.

Authors:  Toufic J Maalouf; Gilles Dolivet; Karine S Angioi; Agnes Leroux; Pascal Genin; Jean-Luc George
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 Jan-Feb       Impact factor: 1.746

3.  Incidence of ocular melanoma in Australia from 1990 to 1998.

Authors:  Claire M Vajdic; Anne Kricker; Michael Giblin; John McKenzie; Joanne Aitken; Graham G Giles; Bruce K Armstrong
Journal:  Int J Cancer       Date:  2003-05-20       Impact factor: 7.396

4.  Long-term follow-up of patients with conjunctival melanoma.

Authors:  Cornelia Werschnik; Peter K Lommatzsch
Journal:  Am J Clin Oncol       Date:  2002-06       Impact factor: 2.339

5.  Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.

Authors:  Madhavi Kurli; Paul T Finger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-07       Impact factor: 3.117

6.  Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma.

Authors:  Yacoub A Yousef; Paul T Finger
Journal:  Arch Ophthalmol       Date:  2012-05

7.  Conjunctival melanoma in the Netherlands: a nationwide study.

Authors:  Guy S Missotten; Sander Keijser; Rob J W De Keizer; Didi De Wolff-Rouendaal
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

8.  Conjunctival melanoma: is it increasing in the United States?

Authors:  Guo-Pei Yu; Dan-Nin Hu; Steven McCormick; Paul T Finger
Journal:  Am J Ophthalmol       Date:  2003-06       Impact factor: 5.258

Review 9.  [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].

Authors:  Peter K Lommatzsch; Cornelia Werschnik
Journal:  Klin Monbl Augenheilkd       Date:  2002-10       Impact factor: 0.700

10.  Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis).

Authors:  Bita Esmaeli; Dianna Roberts; Merrick Ross; Melissa Fellman; Hilda Cruz; Stella K Kim; Victor G Prieto
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12
View more
  3 in total

Review 1.  Sentinel lymph node biopsy in the management of conjunctival melanoma: current insights.

Authors:  Joel M Mor; Alexander C Rokohl; Konrad R Koch; Ludwig M Heindl
Journal:  Clin Ophthalmol       Date:  2019-07-23

Review 2.  Melanoma and Nanotechnology-Based Treatment.

Authors:  Hong Zeng; Jia Li; Kai Hou; Yiping Wu; Hongbo Chen; Zeng Ning
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

3.  Conjunctival Melanoma Angiotropic Microsatellitosis: A Mechanism of Local Extravascular Migratory Metastasis.

Authors:  Jose J Echegaray; Gabrielle Yeaney; Rachel Chen; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2020-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.